GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

VentriPoint Diagnostics VPT.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.07

-7.14%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

VentriPoint Diagnostics — daily TSXV:VPT Delayed
Market value
C$12.2m
Last close × shares
Volume
141.1k
Shares, 9 Nov 2026

About VentriPoint Diagnostics

Its shares trade on TSX Venture under the ticker VPT.V. It has been listed since 9 November 2005. In the fiscal year to 31 December 2025, it reported revenue of C$179,928 and a net loss of C$3.2m. At that date it held total assets of C$472,082 and shareholders' equity of −C$4.1m.

VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The firm is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

Figures and description from our data supplier, not checked against the company's own report.

More about VentriPoint Diagnostics →

Latest on VentriPoint Diagnostics

Our reporting

We have not reported on VentriPoint Diagnostics yet.

Next results

26 Nov 2026

Due on 26 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is VentriPoint Diagnostics's ticker?

VentriPoint Diagnostics trades as VPT.V on TSX Venture, under ISIN CA92281P2008.

What was VentriPoint Diagnostics's last closing price?

0.07 on 9 Nov 2026. The figure is in CAD and is never converted.

When does VentriPoint Diagnostics next report results?

Results are expected on 26 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.